A channel for cardiology news and updates.

Cardio Buzz
Claim This Podcastby Dr. Hussien Heshmat
Podcast Authority
Beta
Podcast Overview
A channel for cardiology news and updates.
Language
🇺🇲
Publishing Since
12/24/2021
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for Cardio Buzz
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

August 8, 2025
Decoding Hypertension: The Surprising Truth About Primary Aldosteronism
Title: Unmasking the Hidden Epidemic: Primary Aldosteronism In the realm of hypertension, primary aldosteronism (PA) emerges as a critical but often overlooked player. Frequently misdiagnosed, PA presents unique challenges and opportunities in patient care. But why should we care about it, and how can we navigate its complexities? #PrimaryAldosteronism #Hypertension **Diagnosis and Screening** Diagnosing PA is paramount yet straightforward, involving a blood test measuring aldosterone and renin levels. Shockingly, less than 1% of hypertensive patients are screened for PA, despite its presence in up to 15% of cases. Screening is essential for anyone with hypertension, particularly those with type 2 diabetes, unexplained atrial fibrillation, or resistant hypertension. #ScreeningMatters #BloodPressure **Treatment Options** For unilateral PA, adrenalectomy offers a surgical cure, significantly enhancing blood pressure control and quality of life. However, it carries surgical risks and may lead to glucocorticoid insufficiency post-operation. For bilateral PA, lifelong medical therapy with mineralocorticoid receptor antagonists helps manage symptoms and reduce health risks. #Adrenalectomy #MedicalTherapy **The Impact** Primary aldosteronism is more than just high blood pressure. It heightens the risk of stroke and kidney disease by over double and places patients at thrice the risk for atrial fibrillation. By identifying and treating PA appropriately, we not only improve blood pressure management but also significantly reduce cardiovascular and renal complications. #HealthInnovation #Endocrinology In summary, screening for PA can significantly transform hypertension management, offering a pathway to targeted therapies. For those navigating hypertension’s complexities, considering primary aldosteronism might just be the game changer we need. Remember, effective diagnosis and tailored treatment hold the key to better health outcomes. Stay informed, stay healthy. #Cardiology #HealthcareR

March 30, 2025
My heart failure patient is hypotensive, Now What?
Is low blood pressure hindering your heart failure treatment? How do you balance life-saving medications with hypotension? We explore the definitions, causes, and practical solutions to optimize patient care. Learn how to navigate ARNI, beta-blockers, SGLT2 inhibitors, and MRAs effectively.

March 7, 2025
Do Medications Leave a Legacy? What You Should Know
In this episode of Cardio Buzz, we explore the intriguing concept of the 'legacy effect' of medications like those used in treating diabetes, hypertension, hypercholesterolemia, and chronic kidney disease. We'll delve into landmark studies like the UKPDS, Steno-2, and more, examining the lasting impacts of medications such as Repatha, Candesartan, and Empagliflozin. Learn how these drugs contribute to disease regression, modify genes, and prevent non-fatal events to grant long-term protective effects. 00:00 Introduction: The Challenge of Lifelong Medication 00:57 Exploring the Legacy Effect of Medications 01:33 Diabetes Medications: Long-Term Benefits 03:15 Hypertension Medications: Persistent Effects 03:58 Cholesterol Medications: Lasting Impact 04:49 Kidney Disease Medications: Prolonged Benefits 06:12 Understanding the Legacy Effect Mechanism 09:13 Implications and Final Thoughts
49 total episodes available
Deep-dive analytics for Cardio Buzz
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Cardio Buzz?
- How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.